MPM Oncology Impact Management LP, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 73,750 shares at $20.49 ($1.5M) on 2021-04-15, disclosed to the SEC on 2021-04-15.
Open-market sale of $1.5M HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.35 | 13,692 | $265K | 17.8% |
| 2 | $19.35 | 13,692 | $265K | 17.8% |
| 3 | $20.08 | 2,362 | $47K | 3.2% |
| 4 | $20.06 | 1,000 | $20K | 1.3% |
| 5 | $20.83 | 12,806 | $267K | 17.9% |
| 6 | $20.83 | 12,806 |
| $267K |
| 17.9% |
| 7 | $20.49 | 8,696 | $178K | 12.0% |
| 8 | $20.49 | 8,696 | $178K | 12.0% |
| Total | $20.17 avg | 73,750 | $1.5M | 100% |
| Filing → |
| ITOS | SELL | 2021-04-13 | $6K | — | Filing → |
| ITOS | SELL | 2021-04-09 | $2.5M | — | Filing → |
| CGEM | BUY | 2021-01-14 | $6.3M | — | Filing → |